Please select the option that best describes you:
Topics:
Breast Cancer • Radiation Oncology
What is your preferred approach to PMRT with inflammatory breast cancer with adverse risk features?
What is your preferred approach to PMRT with inflammatory breast cancer with adverse risk features (i.e. age <45, close/positive margins or poor response to neoadjuvant therapy)?
Answer from: Radiation Oncologist at Academic Institution
Inflammatory breast cancer is most commonly triple negative or HER2 amplified disease. Patients with significant residual disease after preoperative chemotherapy have extremely high rates of relapse. Participation on SWOG1706 (NCT03598257, @Reshma Jagsi PI), a phase II randomized trial of ...
Comments
Radiation Oncologist at University of Texas MD Anderson Cancer Center
We offer BID radiation to the chest wall and nodes...
We offer BID radiation to the chest wall and nodes...
Radiation Oncologist at Northwestern University
I'd just like to put in a plug for listening to th...
I'd just like to put in a plug for listening to th...
Agreed, I use standard fractionation with a boost...
I concur with others and emphasize the use of dail...